微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Fulcrum Therapeutics (NASDAQ:FULC) +125%
Exagen (NASDAQ:XGN) +24%
Myomo (NYSE:MYO) +16%
IMV (NASDAQ:IMV) +8%
Allied Healthcare Products (NASDAQ:AHPI) +6%
Losers:...查看全文
$Exagen(XGN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001843113-22-000008 Size: 6 KB 网页链接
$Exagen(XGN)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001274737-22-000065 Act: 33 Size: 592 KB 网页链接
$Exagen(XGN)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001274737-22-000064 Act: 34 Size: 545 KB 网页链接
$Exagen(XGN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001274737-22-000052 Act: 34 Size: 6 MB 网页链接
$Exagen(XGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001274737-22-000051 Act: 34 Size: 307 KB 网页链接
$Exagen(XGN)$ 8-K Current report, item 5.07 Accession Number: 0001274737-22-000039 Act: 34 Size: 181 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-22-000040 Size: 5 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-22-000041 Size: 5 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-22-000042 Size: 5 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-22-000043 Size: 5 KB 网页链接